Marvell Technology, Inc. filed a Form 8-K on November 2, 2026, disclosing that on November 1, 2026, it entered into an Agreement and Plan of Merger with Lumentum Holdings Inc., under which each Lumentum common share would be exchanged for 4.500 shares of Marvell common stock.

Key Highlights

  • Exchange ratio: Each share of Lumentum common stock will be converted into the right to receive 4.500 shares of Marvell common stock, with cash paid in lieu of fractional shares.
  • Preferred stock option: Holders of Lumentum Series A Convertible Preferred Stock may elect to receive one share of Marvell Series B Convertible Preferred Stock per Lumentum preferred share instead of common stock.
  • Board approval: The Marvell Board unanimously approved the Merger Agreement and declared it advisable, and resolved to recommend stockholder approval of the Charter Amendment and Share Issuance.
  • Post-closing governance: Marvell will appoint three individuals designated by Lumentum from its board of directors to the Marvell Board immediately following the closing.
  • Equity award conversion: Outstanding Lumentum stock options, restricted stock units, and performance stock units will be converted into equivalent Marvell equity awards using the 4.500 exchange ratio, with performance stock units converted solely into time-vesting restricted stock units.
  • Regulatory and stockholder steps: Marvell and Lumentum will jointly prepare and file a registration statement on Form S-4 with the SEC, which will include a joint proxy statement for stockholder meetings at both companies.

Marvell and Lumentum Merger Agreement: Structure and Key Terms

According to the filing, the transaction is structured as a two-step merger. In the First Merger, Merger Sub I, a wholly owned subsidiary of Marvell, will merge with and into Lumentum, leaving Lumentum as the surviving corporation and a wholly owned subsidiary of Marvell. Promptly following that step, Lumentum will then merge with and into Merger Sub II, another wholly owned Marvell subsidiary, which will be the surviving entity of the Second Merger. The filing identifies Marvell as a Delaware corporation trading under the symbol MRVL on NASDAQ:MRVL.

The filing describes the merger consideration in detail. Each share of Lumentum common stock, par value $0.001 per share, outstanding immediately before the Effective Time will be converted into 4.500 shares of Marvell common stock, par value $0.002 per share. For holders of Lumentum Series A Convertible Preferred Stock, the default treatment mirrors the common stock path - converted based on the number of Lumentum common shares into which the preferred is convertible, multiplied by the 4.500 exchange ratio. However, the filing states that a holder may instead elect to receive one share of Marvell Series B Convertible Preferred Stock per Lumentum preferred share. The Marvell Series B Preferred Stock is described in the filing as intended to "have the same terms and rights as the Lumentum Series A Preferred Stock, except that each share is convertible for the Preferred Common Stock Merger Consideration."

With respect to equity awards, the filing states that Lumentum stock options and restricted stock units will be converted into equivalent Marvell awards using the 4.500 exchange ratio, preserving existing vesting conditions. Exercise prices for converted options will be recalculated by dividing the original Lumentum option exercise price by the exchange ratio. Non-employee director restricted stock units of Lumentum will instead be cancelled and converted into the right to receive the Common Stock Merger Consideration. The filing also notes that the shares of Marvell common stock to be issued will be listed on the Nasdaq Global Select Market, and that a Form S-4 registration statement will be filed with the SEC as promptly as reasonably practicable.

What Was Disclosed

Marvell Technology, Inc. disclosed entry into a merger agreement to acquire Lumentum Holdings Inc. in an all-stock transaction signed November 1, 2026, with each Lumentum common share exchangeable for 4.500 Marvell common shares, subject to stockholder and regulatory approvals.